The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virus
Open Access
- 1 May 2012
- journal article
- research article
- Published by Pleiades Publishing Ltd in Molecular Biology
- Vol. 46 (3) , 473-480
Abstract
Hepatitis C is related to the most important socially significant human infectious diseases. However, there is no vaccine for the hepatitis C virus. The nonstructural protein NS3 of the hepatitis C virus (HCV), which is synthesyzed in the infected cells and it displays protease, NTPase, and helicase enzymatic activities, is one of the possible components of the vaccine. The connection between the effectiveness of the T-cell response to NS3 epitopes and the spontaneous resolution of acute hepatitis C has been shown. The purpose of this work was to compare the immune response of mice to the inoculation of the nucleotide and amino acid sequences of HCV NS3 and their combination, as well as to evaluate the adjuvant activity of the DNA encoding of granulocyte macrophage colony-stimulating factor (GM-CSF) and the influence of regulatory T cells on the effectiveness of the immune response. The maximum anti-HCV NS3 antibody level in the serum (up to 1: 640000) induced the recombinant rNS3 protein introduced with aluminum hydroxide. The most intensive cellular immune response was observed after the simultaneous administration of rNS3 and DNAs encoding full-size NS3 and GM-CSF. A high level of lymphocyte proliferation, accumulation of IFN-γ-secreting cells, and IFN-γ/IL-2 release in response to the stimulators (NS3 antigens of different compositions) were observed in this group of mice. It has been established that the in vitro suppression of regulatory T cells leads to a statistically significant increase in the secretion of IFN-γ. Thus, the simultaneous application of rNS3, along with the DNAs encoding full-size NS3 and GM-CSF, is a promising approach to the development of hepatitis C vaccine. The expediency of adding regulatory T-cell inhibitors in the vaccine composition will be clear after special studies.Keywords
This publication has 27 references indexed in Scilit:
- Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosisJournal of Hepatology, 2010
- The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunizationVaccine, 2010
- Induction of multispecific Th-1 type immune response against HCV in mice by protein immunization using CpG and Montanide ISA 720 as adjuvantsVaccine, 2008
- Development of the system ensuring a high-level expression of hepatitis C virus nonstructural NS5B and NS5A proteinsProtein Expression and Purification, 2006
- Prospective study of viral clearance and CD4+ T-cell response in acute hepatitis C primary infection and reinfectionJournal of Clinical Virology, 2006
- Comprehensive Analyses of CD8+ T Cell Responses During Longitudinal Study of Acute Human Hepatitis C *Hepatology, 2005
- Comparison of the Adjuvant Activity for the Glucosaminyl-Muramyl Dipeptide and the Granulocyte-Macrophage Colony-Stimulating Factor Gene in Gene Immunization against the Herpes Simplex VirusMolecular Biology, 2005
- An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infectionHepatology, 2004
- DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3) of human hepatitis C virusImmunology Letters, 2003
- Human and murine antibody recognition is focused on the ATPase/Helicase, but not the protease domain of the hepatitis C virus nonstructural 3 proteinHepatology, 1998